172 related articles for article (PubMed ID: 28008571)
61. Brief fixation does not hamper the reliability of Ki67 analysis in breast cancer core-needle biopsies: a double-centre study.
Kalkman S; Bulte JP; Halilovic A; Bult P; van Diest PJ
Histopathology; 2015 Feb; 66(3):380-7. PubMed ID: 25234295
[TBL] [Abstract][Full Text] [Related]
62. Meta-analysis of the concordance of histological grade of breast cancer between core needle biopsy and surgical excision specimen.
Knuttel FM; Menezes GL; van Diest PJ; Witkamp AJ; van den Bosch MA; Verkooijen HM
Br J Surg; 2016 May; 103(6):644-655. PubMed ID: 26990850
[TBL] [Abstract][Full Text] [Related]
63. Core Needle Biopsy in Lymphoma Diagnosis: The Diagnostic Performance and the Role of the Multidisciplinary Approach in the Optimization of Results.
Gonçalves MC; de Oliveira CRGCM; Sandes AF; Rodrigues CA; Novis Y; Viana PCC; Serra MMP; Zerbini MCN
Am J Surg Pathol; 2023 Jan; 47(1):111-123. PubMed ID: 36395467
[TBL] [Abstract][Full Text] [Related]
64. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
Yang Z; Tang LH; Klimstra DS
Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513
[TBL] [Abstract][Full Text] [Related]
65. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
[TBL] [Abstract][Full Text] [Related]
66. Ki67 Immunohistochemistry Quantification in Breast Carcinoma: A Comparison of Visual Estimation, Counting, and ImmunoRatio.
van den Berg EJ; Duarte R; Dickens C; Joffe M; Mohanlal R
Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):105-111. PubMed ID: 32590453
[TBL] [Abstract][Full Text] [Related]
67. Diagnosing Lymphoproliferative Disorders Using Core Needle Biopsy Versus Surgical Excisional Biopsy: Three-Year Experience of a Reference Center in Lebanon.
Assaf N; Nassif S; Tamim H; Bazarbachi A; Zaatari G; Chakhachiro Z
Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):e455-e460. PubMed ID: 32461041
[TBL] [Abstract][Full Text] [Related]
68. Unsuccessful preoperative biopsies, fine needle aspiration cytology or core needle biopsy, lead to increased costs in the diagnostic workup in breast cancer.
Hukkinen K; Kivisaari L; Heikkilä PS; Von Smitten K; Leidenius M
Acta Oncol; 2008; 47(6):1037-45. PubMed ID: 18607862
[TBL] [Abstract][Full Text] [Related]
69. Comparison of Core Needle Biopsy and Excision Specimens for the Accurate Evaluation of Breast Cancer Molecular Markers: a Report of 1003 Cases.
Chen J; Wang Z; Lv Q; Du Z; Tan Q; Zhang D; Xiong B; Zeng H; Gou J
Pathol Oncol Res; 2017 Oct; 23(4):769-775. PubMed ID: 28074330
[TBL] [Abstract][Full Text] [Related]
70. Prognostic significance of the progesterone receptor status in Ki67-high and -low Luminal B-like HER2-negative breast cancers.
Sato K; Miyashita M; Ishida T; Suzuki A; Tada H; Watanabe G; Sato-Tadano A; Watanabe M; Ohuchi N
Breast Cancer; 2016 Mar; 23(2):310-7. PubMed ID: 25380989
[TBL] [Abstract][Full Text] [Related]
71. Application of the British National Health Service Breast Cancer Screening Programme classification in 226 breast core needle biopsies: correlation with resected specimens.
Pagni F; Bosisio FM; Salvioni D; Colombo P; Leone BE; Di Bella C
Ann Diagn Pathol; 2012 Apr; 16(2):112-8. PubMed ID: 22056037
[TBL] [Abstract][Full Text] [Related]
72. Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis.
Chen X; Yuan Y; Gu Z; Shen K
Breast Cancer Res Treat; 2012 Aug; 134(3):957-67. PubMed ID: 22370627
[TBL] [Abstract][Full Text] [Related]
73. Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.
Leung SCY; Nielsen TO; Zabaglo LA; Arun I; Badve SS; Bane AL; Bartlett JMS; Borgquist S; Chang MC; Dodson A; Ehinger A; Fineberg S; Focke CM; Gao D; Gown AM; Gutierrez C; Hugh JC; Kos Z; Laenkholm AV; Mastropasqua MG; Moriya T; Nofech-Mozes S; Osborne CK; Penault-Llorca FM; Piper T; Sakatani T; Salgado R; Starczynski J; Sugie T; van der Vegt B; Viale G; Hayes DF; McShane LM; Dowsett M;
Histopathology; 2019 Aug; 75(2):225-235. PubMed ID: 31017314
[TBL] [Abstract][Full Text] [Related]
74. Clinicopathological significance of 'atypical ductal proliferation' in core needle biopsy of the breast.
Abe E; Suzuki K; Hayashi N; Yang Y; Li CP; Uno M; Akiyama F; Yamauchi H; Nakamura S; Tsugawa K; Tsunoda H; Ohde S; Sasano H
Pathol Int; 2014 Feb; 64(2):58-66. PubMed ID: 24629173
[TBL] [Abstract][Full Text] [Related]
75. [Ultrasound-guided core needle biopsy in the diagnosis of breast lesions].
Fan ZQ; Ouyang T; Wang TF; Li JF; Xie YT; Fan T; Zhang Z; Lin BY
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(17):1185-7. PubMed ID: 18067713
[TBL] [Abstract][Full Text] [Related]
76. Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.
Yagi T; Inoue N; Yanai A; Murase K; Imamura M; Miyagawa Y; Enomoto Y; Nishimukai A; Takatsuka Y; Hirota S; Akazawa K; Miyoshi Y
Breast Cancer; 2016 Mar; 23(2):224-30. PubMed ID: 25082658
[TBL] [Abstract][Full Text] [Related]
77. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
78. US-guided 14-gauge core-needle breast biopsy: results of a validation study in 1352 cases.
Schueller G; Jaromi S; Ponhold L; Fuchsjaeger M; Memarsadeghi M; Rudas M; Weber M; Liberman L; Helbich TH
Radiology; 2008 Aug; 248(2):406-13. PubMed ID: 18641246
[TBL] [Abstract][Full Text] [Related]
79. A randomised pilot study comparing 13 G vacuum-assisted biopsy and conventional 14 G core needle biopsy of axillary lymph nodes in women with breast cancer.
Maxwell AJ; Bundred NJ; Harvey J; Hunt R; Morris J; Lim YY
Clin Radiol; 2016 Jun; 71(6):551-7. PubMed ID: 27040801
[TBL] [Abstract][Full Text] [Related]
80. Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study.
Varga Z; Cassoly E; Li Q; Oehlschlegel C; Tapia C; Lehr HA; Klingbiel D; Thürlimann B; Ruhstaller T
PLoS One; 2015; 10(4):e0123435. PubMed ID: 25885288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
